(BF-B) Brown-Forman - Ratings and Ratios
Whiskey, Bourbon, Tequila, Gin, Brandy
Dividends
| Dividend Yield | 3.08% |
| Yield on Cost 5y | 1.32% |
| Yield CAGR 5y | 5.84% |
| Payout Consistency | 85.9% |
| Payout Ratio | 53.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 34.1% |
| Value at Risk 5%th | 52.6% |
| Relative Tail Risk | -6.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -42.07 |
| CAGR/Max DD | -0.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.400 |
| Beta | 0.568 |
| Beta Downside | 0.426 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.30% |
| Mean DD | 30.95% |
| Median DD | 31.93% |
Description: BF-B Brown-Forman October 30, 2025
Brown-Forman (NYSE: BF-B) is a global producer and marketer of alcoholic beverages, covering a portfolio that spans whiskey (Jack Daniel’s, Woodford Reserve, Old Forester, Gentleman Jack), tequila (Herradura, el Jimador), gin (Fords Gin), Scotch malt (The Glendronach, Benriach, Glenglassaugh), and a range of ready-to-drink and bottled-in-bond products. The firm also generates ancillary revenue from used-barrel sales, bulk whiskey and wine, and contract bottling services, distributing through a mix of independent distributors, state and provincial governments, and direct retail channels across North America, Europe, Asia-Pacific and Latin America.
Key recent metrics (FY 2023): net sales of approximately $4.5 billion, an operating margin of ~22 % and free cash flow of $1.1 billion, reflecting strong premium-segment pricing power. The company’s growth is driven by continued “premiumization” trends-U.S. consumers are allocating a higher share of discretionary spend to higher-priced spirits, while emerging-market demand for tequila and ready-to-drink cocktails is expanding. A material risk factor is the sensitivity of sales to macro-economic cycles and regulatory changes (e.g., excise tax adjustments), which can compress margins if consumer spending tightens.
For a deeper, data-driven look at how these dynamics translate into valuation outlook, you might explore the detailed analyst models on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (810.0m TTM) > 0 and > 6% of Revenue (6% = 233.3m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 71.87% (prev 64.80%; Δ 7.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 761.0m <= Net Income 810.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.33b) to EBITDA (1.19b) ratio: 1.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (472.6m) change vs 12m ago -0.10% (target <= -2.0% for YES) |
| Gross Margin 59.12% (prev 59.21%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.99% (prev 48.96%; Δ -1.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.72 (EBITDA TTM 1.19b / Interest Expense TTM 106.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.05
| (A) 0.34 = (Total Current Assets 4.21b - Total Current Liabilities 1.42b) / Total Assets 8.22b |
| (B) 0.59 = Retained Earnings (Balance) 4.89b / Total Assets 8.22b |
| (C) 0.10 = EBIT TTM 818.0m / Avg Total Assets 8.28b |
| (D) 1.15 = Book Value of Equity 4.72b / Total Liabilities 4.09b |
| Total Rating: 6.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.24
| 1. Piotroski 5.50pt |
| 2. FCF Yield 3.65% |
| 3. FCF Margin 15.69% |
| 4. Debt/Equity 0.64 |
| 5. Debt/Ebitda 1.96 |
| 6. ROIC - WACC (= 2.84)% |
| 7. RoE 20.33% |
| 8. Rev. Trend -38.28% |
| 9. EPS Trend 5.02% |
What is the price of BF-B shares?
Over the past week, the price has changed by -0.03%, over one month by +9.38%, over three months by +8.82% and over the past year by -32.43%.
Is BF-B a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 10
- Sell: 3
- Strong Sell: 2
What are the forecasts/targets for the BF-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31 | 4.5% |
| Analysts Target Price | 31 | 4.5% |
| ValueRay Target Price | 26 | -12.2% |
BF-B Fundamental Data Overview December 07, 2025
P/E Trailing = 17.7778
P/E Forward = 18.3824
P/S = 3.6993
P/B = 3.567
P/EG = 4.5925
Beta = 0.41
Revenue TTM = 3.89b USD
EBIT TTM = 818.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 2.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 575.0m USD (from shortTermDebt, last quarter)
Debt = 2.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 16.71b USD (14.39b + Debt 2.65b - CCE 319.0m)
Interest Coverage Ratio = 7.72 (Ebit TTM 818.0m / Interest Expense TTM 106.0m)
FCF Yield = 3.65% (FCF TTM 610.0m / Enterprise Value 16.71b)
FCF Margin = 15.69% (FCF TTM 610.0m / Revenue TTM 3.89b)
Net Margin = 20.83% (Net Income TTM 810.0m / Revenue TTM 3.89b)
Gross Margin = 59.12% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 59.36% (prev 59.74%)
Tobins Q-Ratio = 2.03 (Enterprise Value 16.71b / Total Assets 8.22b)
Interest Expense / Debt = 0.87% (Interest Expense 23.0m / Debt 2.65b)
Taxrate = 19.71% (55.0m / 279.0m)
NOPAT = 656.7m (EBIT 818.0m * (1 - 19.71%))
Current Ratio = 2.97 (Total Current Assets 4.21b / Total Current Liabilities 1.42b)
Debt / Equity = 0.64 (Debt 2.65b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.96 (Net Debt 2.33b / EBITDA 1.19b)
Debt / FCF = 3.82 (Net Debt 2.33b / FCF TTM 610.0m)
Total Stockholder Equity = 3.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.85% (Net Income 810.0m / Total Assets 8.22b)
RoE = 20.33% (Net Income TTM 810.0m / Total Stockholder Equity 3.98b)
RoCE = 12.77% (EBIT 818.0m / Capital Employed (Equity 3.98b + L.T.Debt 2.42b))
RoIC = 9.80% (NOPAT 656.7m / Invested Capital 6.70b)
WACC = 6.96% (E(14.39b)/V(17.03b) * Re(8.11%) + D(2.65b)/V(17.03b) * Rd(0.87%) * (1-Tc(0.20)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.73%
[DCF Debug] Terminal Value 77.80% ; FCFE base≈549.2m ; Y1≈539.3m ; Y5≈551.8m
Fair Price DCF = 31.89 (DCF Value 9.68b / Shares Outstanding 303.6m; 5y FCF grow -2.73% → 3.0% )
EPS Correlation: 5.02 | EPS CAGR: -3.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: -38.28 | Revenue CAGR: -0.03% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.46 | Chg30d=-0.007 | Revisions Net=+2 | Analysts=14
EPS current Year (2026-04-30): EPS=1.64 | Chg30d=+0.001 | Revisions Net=-1 | Growth EPS=-10.8% | Growth Revenue=-3.3%
EPS next Year (2027-04-30): EPS=1.74 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+5.8% | Growth Revenue=+1.4%
Additional Sources for BF-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle